Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Monofocal hepatocellular carcinoma: How much does size matter?Filippo Pelizzaro, Barbara Penzo, Giulia Peserico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2019
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort studyAlessandro Vitale, Fabio Farinati, Timothy M Pawlik, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2020
The changing scenario of hepatocellular carcinoma in Italy: an updateFrancesca Garuti, Andrea Neri, Francesca Avanzato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2022
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitorsBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Monofocal hepatocellular carcinoma: How much does size matter?Filippo Pelizzaro, Barbara Penzo, Giulia Peserico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2019
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort studyAlessandro Vitale, Fabio Farinati, Timothy M Pawlik, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2020
The changing scenario of hepatocellular carcinoma in Italy: an updateFrancesca Garuti, Andrea Neri, Francesca Avanzato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2022
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitorsBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Pageof 21